-46.6%
COIN vs MRNA
-6.3%
-40.3%
-90.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | +5.4% | -3.7% | +0.8% |
| 7D | -5.1% | -1.1% | -4.0% | -4.9% |
| 30D | +17.6% | +126.1% | -108.5% | -13.5% |
| 3M | +9.2% | +190.0% | -180.8% | -26.9% |
| 6M | -11.8% | +157.2% | -169.0% | -38.9% |
| YTD | -22.5% | +388.2% | -410.7% | -56.9% |
| 1Y | -45.9% | +467.0% | -512.9% | -71.8% |
| 3Y | +117.4% | +36.1% | +81.3% | +64.0% |
| 5Y | -29.4% | -68.0% | +38.5% | -33.5% |
| All | -46.6% | -6.3% | -40.3% | -59.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling